Weight-loss drugs can cut future health costs. The fight is over who pays now.
A new analysis found that semaglutide and tirzepatide offer great health benefits over a lifetime, but the immense scale of their potential use makes them hard to afford.
AI brief
Pulse reads the full article- What happened
- Why it matters
- What to watch
Sign in to get the AI brief. Pulse explains what happened, why it matters, what to watch and who's exposed. Free for members.
Sign in to read the brief